Anna M. Spiros

FDA investigator

Appears on 6 documents from 2024 to 2026, most often at sites in Michigan. Most often cites written procedures; deviations (21 CFR 211.100).

6
Documents on file
4.3
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 26 observations

Activity by year

2024: 1, 2025: 3, 2026: 2

Where

Michigan 2 · Ohio 2 · New York 1

Is Anna M. Spiros coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 STAQ Pharma of Ohio, LLCAug 19, 2026 · Columbus, Ohio
483 GOJO Industries LLCApr 9, 2026
483 Smithfield Biosciences, IncDec 23, 2025 · Cincinnati, Ohio
483 Pine Pharmaceuticals, LLCNov 14, 2025 · Tonawanda, New York
483 L. Perrigo CompanyMar 19, 2025 · Allegan, Michigan
483 CEB Michigan IncOct 17, 2024 · Edwardsburg, Michigan

About this profile

What does Anna M. Spiros inspect?

Anna M. Spiros appears on 6 documents on file covering 6 sites, most often in Michigan.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Anna M. Spiros is dated Aug 19, 2026.